The Laboratory Robotics Interest Group

June 1998 Meeting

The Fourth Annual Vendor's Night

Date:        Thursday, June 11, 1998
Place:       Forsgate Country Club, Forsgate Drive, Jamesburg, NJ 08831
                  Phone: (732)521-0070
Itinerary:  Exhibitions - 4:30 to 10:00 PM
                 Presentations - 7:00 to 9:30 PM
Member Pre-Registration: Requested, not required.  Pre-registering will allow us to more accurately gauge seating requirements and refreshment needs.  Indicate names of attendees and company affiliation.  Pre-register by email with <mailto:[email protected]> or by phone at (732)302-1038.  In order to speed sign-in at the meeting, please bring a business card to drop into the registration box.  There will be a business card drawing for one of our beautiful LRIG rosewood pens.
Exhibitor Registration Information may be found at https://www.lab-robotics.org/0698vn.htm


Agenda:  Sixty-four vendor tables of laboratory automation hardware and software will exhibit, demonstrating their latest products and services. Presentations are featured in a separate hall during the exhibition. To be considered for a presentation slot, please send us an abstract.  Extensive hors d’oerves, courtesy of the vendors, will be available as well as a cash bar. The proceeds from this vendor funded exhibition are used to finance mailings and pay for various costs of running the group. In this way the LRIG can operate without collecting dues. Please support the group by attending this informative and entertaining meeting.  Last year’s Vendor’s Night was extremely successful and we hope to surpass that turnout. For exhibitor registration or more information contact Andy Zaayenga <[email protected]>, Secretary, or any of the LRIG officers listed below.

There are hotels nearby for attendees who wish to stay overnight.

 Members interested in presenting a poster are encouraged to do so.  Open career positions at your company may be announced or posted.  There is no fee to attend the meeting.


Exhibiting Vendors

Absorption Systems LJL Biosystems
Airfiltronix Corp. Marsh Biomedical Products
Amersham Pharmacia Biotech Matrix Technologies Corp.
Argonaut Technologies MDL Information Systems
Beckman Instruments Inc. Millipore
Becton Dickinson Labware Molecular Devices Corporation
Bohdan Automation Inc. Nalge Nunc International
Brandel Biomedical NEN Life Science Products Inc.
Cartesian Technologies, Inc. Packard Instruments
Charybdis Technologies, Inc. PerSeptive Biosystems
Comdisco Laboratory & Scientific Group Robbins Scientific Corporation
Corning, Inc. Robocon Inc.
CRS Robotics Corporation Skatron Instruments
Datavision Inc. Source For Automation Inc.
EG&G Wallac Inc. ST Robotics International
EMAX Solution Partners Tecan US Inc.
Fisher Scientific TekCel
GeneVac Titertek Instruments
Gensym Corporation Tomtec Inc.
Gilson Inc. Triad Scientific
Greiner America Tropix Inc.
Groton Neochem LLC Universal Imaging Corporation
Hamilton Company USA / Scientific Plastics
Hudson Control Group Inc. Vangard International Inc.
IGEN Waters Corporation
InnovaSystems Inc. Whatman/Polyfiltronics
Labman Automation Ltd Xenopore Corporation
LEAP Technologies Inc. Zymark Corporation

Presentation:  Design strategy and implementation of an automated system for performing Ultra High Throughput Screening using the current generation of assay technologies
Mary Jo Wildey, Ph.D.
Research Fellow, New Leads Discovery,
Robert Wood Johnson PRI, Raritan, NJ
Brian Lightbody
Zymark Corporation

Expanding the new drug development pipeline is one of the keys to the race to market for new drugs. Despite a number of promising new developments in combinatorial chemistry and rational drug design most new leads still come from empirical testing. This has placed an urgent emphasis on increasing the throughput of screening to rates as high as 100,000 assays/day. While the step to UHTS will offer several long term benefits, successful implementation will depend on reducing the technical risks, maintaining assay flexibility, and leveraging existing down stream and up stream processes.

Some argue that the quantum step to 100,000 points per day will only be realized with new assay technologies and emerging higher density plate formats. This talk will discuss an automated approach which uses robust production validated technology and allows current generation of assays to be run at UHTS rates - today, with the flexibility to be easily reconfigured to different assay formats, as needs change. Zymark has developed such a solution called Allegro?/font> , and is currently under contract with 4 collaborators. Some of the results of the first beta test with RW Johnson Pharmaceutical Research Institute will be discussed. This includes methods validation data on different assay formats, as well as preliminary evaluation of the technology.


Presentation:  ORIGEN Technology for performing High-Throughput compound screening assays
Charles Grimshaw, Ph.D.
IGEN Corporation

IGEN possesses a proprietary technology which utilizes electrochemiluminescent detection to analyze levels of analytes, enzymatic activities, binding events, nucleic acids, etc.. The technology delivers highly sensitive and precise answers in a homogeneous format, allowing labs to decrease the amount of rare reagents and labor required to discover hits in target assays.


Presentation:  Industry Strategic Benefits and Success Factors in Automation in Pharmaceutical Research
Michelle Palmer
Director, Assay Developmet Services
Mark T. Roskey, Ph.D.
Director, Pharmaceutical Screening Systems
Perkin-Elmer Tropix Inc.


Presentation:  Research Automation: An Integrated Approach to Proprietary and Commercial Substance Supply, Preparation, Tracking, and Request Fulfillment Using Novel Information Management Technology
David A. Kniaz
Project Director
EMAX Solution Partners

Companies that invest in leading combinatorial chemistry and high throughput screening technologies need a way to manage the large volumes of proprietary and commercial substance data created through these automated processes. Research and development organizations can accelerate their drug discovery process and control costs through an integrated substance management solution.

This presentation will discuss how an integrated substance management solution can bring the following basic elements of logistics management into place:

            *     reagent ordering and supply
            *     stockroom management
            *     container tracking
            *     proprietary compound inventory management
            *     micro-titer plate preparation and tracking


Presentation:  An Open, Modular Software Architecture for Laboratory Automation
Carl Murray
Software Development Manager
Beckman / Sagian

Beckman Coulter's new operating environment for laboratory automation is a robot-independent, application-independent architecture that allows applications to be built from reusable, modular components. Each function, such as device control, data logging, labware transportation, or execution control, is managed by an independent module written industry-standard programming tools. A messaging architecture allows these modules to work together, and permits easy integration of any application that supports ActiveX components, such as Microsoft Excel. Data management is standardized, and data can be manipulated by several modules simultaneously. New modules can be introduced without side effects, and old modules can be updated without compromising the upgrade path of the system. An example of a system built with this architecture, Beckman's Core Systems, is used to illustrate the concepts.


Poster:  Software methodology based on 3D molecular information
Siram N. V. Rao


Posters:  Automated Labelling and Weighing Systems

High Throughput Robotic Multistep Sample Preparation Procedure for the
Determination of Sodium Oxalate in Bauxite by Gas Chromatography

Wellplate Replication in High Throughput Screening
Andrew Whitwell
Labman Automation Ltd


For more information contact:

Executive Chair:
Dennis France
dennis.france@
pharma.novartis.com

(973)781-6030
Novartis Pharmaceuticals Corporation
Secretary:
Andy Zaayenga
andy.zaayenga@
tekcel.com

(732)302-1038
TekCel LLC
Analytical Chemistry Chair and Treasurer:
William Haller
bhaller@
ompus.jnj.com

(908)218-6341
Ortho-McNeil
High Throughput Screening Chair:
John Babiak, Ph.D.
babiakj@
war.wyeth.com

(732)274-4788
Wyeth-Ayerst Research
Agricultural Applications Chair:
Sharon Reed
reeds@
pt.cyanamid.com

(609)716-2905
American Cyanamid
Data Management Chair:
Steve Fillers, Ph.D.
william.fillers@
pharma.novartis.com

(908)277-7723
Novartis Pharmaceuticals Corporation
   

Directions:

From the North or South: Take the New Jersey Turnpike to Exit 8A - Exit the left ramp for Jamesburg (Route 32 East) - Continue straight for 1 1/4 miles through traffic light - Forsgate Country Club is on your left - Use the Clubhouse Entrance (second left).

From Princeton: Route 1 to Scudders Mill Road East - Continue on Scudders Mill Road and make a left at the 5th traffic light onto Dey Road - Continue on Dey Road to the end  - Make a left  - At 2nd traffic light (Route 32) make a right - Continue straight for 1 1/4 miles through traffic light - Forsgate Country Club is on your left - Use the Clubhouse entrance (second left).

For an interactive map: [ Yahoo! Maps ]


Group Update:  Paul Skerker of Leukosite and Donna Norton of Pharmalytic won rosewood LRIG pen sets in the business card drawing.   A business card drawing will be held at the June meeting.


Visit The Laboratory Robotics Interest Group homepage at https://www.lab-robotics.org